Hiroaki Yasui
Lund University(SE)Nagoya University(JP)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Protein Degradation and Inhibitors, Ovarian cancer diagnosis and treatment, Intraperitoneal and Appendiceal Malignancies
Most-Cited Works
- → Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway(2020)76 cited
- → PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination(2018)61 cited
- → CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway(2019)60 cited
- → Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance(2022)42 cited
- → The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis(2018)36 cited
- → Regulation of Melanophore Responsiveness in the Background-Adapted Medaka, Oryzias Latipes: Change in the Intracellular Signaling System(1997)11 cited
- → Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma(2024)9 cited
- [A case of adenine phosphoribosyltransferase (APRT) deficiency discovered by urine examination].(1994)
- → Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance(2022)5 cited
- → A dynamic mutational landscape associated with an inter‐regionally diverse immune response in malignant rhabdoid tumour(2020)4 cited